Quote | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
Last: | $1.11 |
---|---|
Change Percent: | -10.81% |
Open: | $1.23 |
Close: | $1.11 |
High: | $1.28 |
Low: | $1.08 |
Volume: | 1,033,183 |
Last Trade Date Time: | 03/06/2024 03:00:00 am |
News | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
2024-04-22 09:18:37 ET More on Panbela Therapeutics Panbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcript Panbela Therapeutics closes ~$9M public offering of shares Panbela Therapeutics drops on $9M public offering Seeking Alpha’s Quant Ra...
MINNEAPOLIS, April 22, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that the interim data analysis for its ...
Message Board Posts | Panbela Therapeutics Inc Com (NASDAQ:PBLA)
Subject | By | Source | When |
---|---|---|---|
$PBLA in the news following $7 price target: | JDCruz | investorshub | 04/28/2023 5:36:13 PM |
$PBLA Price gaining last trade up | TheFinalCD | investorshub | 04/27/2023 6:54:50 PM |
Long and strong lets hope im right | molee | investorshub | 04/27/2023 5:40:48 PM |
Oh , I can relate , as I | molee | investorshub | 04/27/2023 5:19:45 AM |
Can you imagine how the shareholders feel? IMHO | subslover | investorshub | 04/26/2023 7:06:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, April 22, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that the interim data analysis for its ...
MINNEAPOLIS, April 16, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that its common stock has been approved...
MINNEAPOLIS, March 26, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (NASDAQ:PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the...